Abstract

Polycystic ovaries and the associated syndrome are recognized as the most common cause of reproductive and metabolic disorders in adult women, but not much research has been performed especially in Nigeria to examine how polycystic ovary syndrome (PCOS) presents in young and old women alike. Polycystic ovaries have been demonstrated in childhood, and there is evidence to show that even very young women may show symptoms and signs of the associated syndrome. This study aims to assess the level of the awareness of PCOS among young female adults. The descriptive study comprised of One hundred and fifty undergraduate female students (15 - 35 years) from randomly selected Universities in Nigeria were included in the study, of the this, only one hundred and one responses were considered valid. A Google form was created which included a well-structured questionnaire. The questionnaire consisted of three parts with a total of 32 questions in all, formulated to determine sociodemographic status, reproductive indices and knowledge or awareness of PCOS. It was observed that 35% had no idea what PCOS was or how it develops. There is a high need for awareness of PCOS among female adults. Early onset of accurate diagnosis is the key to its management and treatment.

Keywords: Women; Nigeria; PCOS; Infertility; Diabetes; Hereditary

References

1. Adams J., et al. “Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism”. British Medical Journal 293 (1986): 355-359.
2. Rinki SG., et al. “Awareness of polycystic ovarian syndrome in the female dental students among Chennai population”. Drug invention Today 14.3. (2020): 513-515.
3. Nidhi R, et al. “Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial”. International Journal Yoga 5.2 (2012): 112-117.
4. Michelmore KF, et al. “Polycystic ovaries and associated clinical and biochemical features in young women”. Clinical Endocrinology 51 (1999): 779-786.
5. Knochenhauer ES, et al. “Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study”. Journal of Clinical and Endocrinological Metabolism 83 (1998): 3078.
6. Conway GS, et al. “Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients”. Clinical Endocrinology 30 (1989): 459-470.
7. Franks S. “Polycystic ovary syndrome in adolescents”. International Journal of Obstetrics (London) 32 (2008): 1035-1041.
8. Balen AH., et al. “Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients”. Human Reproduction 10 (1995): 2107-2111.
9. Balen A. “Pathogenesis of polycystic ovary syndrome - the enigma unravels?”. Lancet 354 (1999): 966-967.
10. Dunaif A. “Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis”. Endocrinology Review 18.6 (1997): 774-800.
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome”. Fertility and Sterility 81.1 (2004): 19-25.
12. Sunanda B and Sabitha Nayak. “A study to assess the knowledge regarding PCOS (Polycystic Ovarian Syndrome) among Nursing students at NUINS”. Nitte University Journal of Health Science 6.3 (2016): 24-26.
13. Pothiraj Pitchai and SR Sreeraj. “Awareness of lifestyle modification in females diagnosed with polycystic ovarian syndrome in India: explorative study”. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 5.2 (2016): 470-476.
14. Rinki Susan George., et al. “Awareness of polycystic ovarian syndrome in the female dental students among Chennai population”. Drug Invention Today 14.3 (2020).
15. Azziz R, et al. “Androgen excess in women: experience with over 1000 consecutive patients”. Journal of Clinical Endocrinology Metabolism 89.2 (2004): 453-462.
16. Buggs C and Rosenfield RL. “Polycystic ovary syndrome in adolescence”. Endocrinology Metabolism Clinical North America 34.3 (2005): 677-679.
17. Scott Sills E., et al. “Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports”. BMC Women's Health 1 (2001): 3.
18. Himelein MJ and Thatcher SS. “Polycystic ovary syndrome and mental health: A review”. Obstetrics and Gynecology Survey 61.11 (2006): 723-732.
19. Ruksana S., “Awareness of Obesity as a Risk Factor for Polycystic Ovary Syndrome”. Journal of Pharmaceutical Sciences and Research 7.7 (2015): 471-473.
20. Kahsar-Miller MD., et al. “Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS”. Fertility and Sterility 75.1 (2000): 53-58.
21. Goodarzi M., et al. “Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis”. National Review of Endocrinol 7.4 (2011): 219-231. 
22. Kataoka J., et al. “Weight Management Interventions in Women with and without PCOS: A Systematic Review”. Nutrients 9 (2017): 996.
23. Sari Harrar. What causes PCOS? And How will it affect my body. 
24. Pasquali R and Casimirri F. “The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women”. Clinical Endocrinology 39 (1993): 1-16.
25. Diamanti-Kandarakis E. “Insulin resistance and polycystic ovary syndrome through life”. Current Pharmaceutical Design 18.34 (2012): 5569-5576.